Dose-Dependent Increase in Whole Blood Omega-3 Fatty Acid Concentration in Horses Receiving a Marine-Based Fatty-Acid Supplement.
Authors: Pearson Garett, Goodale Margaret, Wakshlag Joseph, Fortier Lisa
Journal: Journal of equine veterinary science
Summary
# Editorial Summary Researchers evaluated whether a marine-based omega-3 supplement produced dose-dependent changes in equine blood fatty acid profiles by administering either 7.5g or 15g daily to 50 healthy horses, with blood analysis via gas chromatography at baseline, 6 weeks, and 12 weeks. Both supplementation doses significantly elevated circulating EPA and DHA concentrations compared to baseline at all timepoints, with the higher dose (15g) producing substantially greater increases than the lower dose (7.5g)—demonstrating clear dose-dependency—whilst also triggering a significant reduction in pro-inflammatory omega-6 fatty acids, particularly in the higher-dose group. The findings suggest that supplementation dose exerts considerably greater influence over blood omega-3 status than duration of treatment, indicating that practitioners seeking rapid shifts in the n-3:n-6 ratio may prioritise dosing strategy over extended supplementation periods. For equine professionals managing conditions associated with inflammatory pathology—including musculoskeletal injuries, gastrointestinal ulceration, and inflammatory airway disease—these results validate marine-based omega-3 products as effective pharmaconutrient tools, though individual response thresholds and optimal dosing for specific clinical presentations warrant further investigation.
Read the full abstract on PubMed
Practical Takeaways
- •Marine-based omega-3 supplements effectively increase blood n3-FA concentrations in horses in a dose-dependent manner; consider higher doses (15g/day) for more substantial shifts in the omega-3:omega-6 ratio
- •Significant changes in blood fatty acid profiles occur within 6 weeks of supplementation, so clinical effects from dietary n3-FA modification may be observed relatively quickly
- •If using this supplement for inflammatory or immune-related conditions, doubling the dose from 7.5g to 15g daily produces meaningfully greater increases in therapeutic fatty acids
Key Findings
- •Group 2 (15g/day) showed significantly greater increases in whole blood omega-3 fatty acids (DHA and EPA) compared to Group 1 (7.5/day) at both 6 and 12 weeks
- •Both treatment groups demonstrated significant decreases in omega-6 fatty acids at 6 weeks, with larger reductions in the higher-dose group
- •Supplement dose had a greater effect on increasing whole blood n3-FAs than duration of treatment (6 vs 12 weeks showed similar dose-dependent patterns)